Colchicine in stable coronary artery disease
ATL Fiolet, SM Nidorf, A Mosterd, JH Cornel - Clinical therapeutics, 2019 - Elsevier
Purpose Disease management of stable coronary artery disease consists of controlling
hemostasis and lipid regulation. No treatment strategies preventing plaque erosion or …
hemostasis and lipid regulation. No treatment strategies preventing plaque erosion or …
Colchicine in Stable Coronary Artery Disease
ATL Fiolet, SM Nidorf, A Mosterd… - Clinical …, 2019 - clinicaltherapeutics.com
Purpose Disease management of stable coronary artery disease consists of controlling
hemostasis and lipid regulation. No treatment strategies preventing plaque erosion or …
hemostasis and lipid regulation. No treatment strategies preventing plaque erosion or …
Colchicine in Stable Coronary Artery Disease.
ATL Fiolet, SM Nidorf, A Mosterd, JH Cornel - Clinical Therapeutics, 2018 - europepmc.org
Purpose Disease management of stable coronary artery disease consists of controlling
hemostasis and lipid regulation. No treatment strategies preventing plaque erosion or …
hemostasis and lipid regulation. No treatment strategies preventing plaque erosion or …
Colchicine in Stable Coronary Artery Disease
ATL Fiolet, SM Nidorf, A Mosterd… - Clinical …, 2019 - pubmed.ncbi.nlm.nih.gov
Purpose Disease management of stable coronary artery disease consists of controlling
hemostasis and lipid regulation. No treatment strategies preventing plaque erosion or …
hemostasis and lipid regulation. No treatment strategies preventing plaque erosion or …
[引用][C] Colchicine in Stable Coronary Artery Disease
ATL Fiolet, SM Nidorf, A Mosterd, JH Cornel - 2019 - repository.ubn.ru.nl
PURPOSE: Disease management of stable coronary artery disease consists of controlling
hemostasis and lipid regulation. No treatment strategies preventing plaque erosion or …
hemostasis and lipid regulation. No treatment strategies preventing plaque erosion or …